Correction to: Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2(V617F)-induced myeloproliferative neoplasms
更正:新型 JAK2/FLT3 抑制剂马来酸氟诺替尼治疗 JAK2(V617F) 诱导的骨髓增生性肿瘤的临床前研究
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-024-01058-y
Hu, Mengshi; Yang, Tao; Yang, Linyu; Niu, Lu; Zhu, Jinbing; Zhao, Ailin; Shi, Mingsong; Yuan, Xue; Tang, Minghai; Yang, Jianhong; Pei, Heying; Yang, Zhuang; Chen, Qiang; Ye, Haoyu; Niu, Ting; Chen, Lijuan